Abstract: Tumor Suppressor Activated Pathway (TSAP) genes and nucleotide sequences therefore as well as vectors and cells containing such nucleotide sequences and various uses therefore are described. The mechanism by which TSAP 3 activates apoptosis also is described. Pharmaceutical compositions and methods for preventing tumorigenesis also is described.
Type:
Grant
Filed:
April 6, 2000
Date of Patent:
January 7, 2003
Assignee:
Société Molecular Engines Laboratories a French
Société anonyme
Inventors:
Adam Telerman, Robert Amson, Daniel Cohen